ConductScience.org, home

Paper41350360

Dysregulation of HOXA genes in acute myeloid leukemia and targeted therapy.

Huang W and 4 others. NPJ Precis Oncol, 2025. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Dysregulation of HOXA genes in acute myeloid leukemia and targeted therapy. Papers, record 41350360. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41350360

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dysregulation of HOXA genes in acute myeloid leukemia and targeted therapy.
PubMed
Journal
NPJ Precis Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.46, provisional
iCite
Revised in PubMed
2025-12-11
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang WWusixian
2Zhang FFenghong
3Zhang ZZhiyu
4Wang QQinrong
5Chen SSuning

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2019YFA0111000National Key Research and Development Program of ChinaPubMed
82470166, 82400188, 82200149, 82170158, 82100175 and 82100170the National Natural Science Foundation of ChinaPubMed
BK20231195, BK20210087the priority academic program development of Jiangsu Higher Education Institution, the Natural Science Foundation of Jiangsu ProvincePubMed

Source PubMed

Download CSV of grants

References194

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116507773c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells.Blood2006https://conductscience.org/library/papers/16507773PubMed
234320268SET-NUP214 and MLL cooperatively regulate the promoter activity of the HoxA10 gene.Genes Cells2021https://conductscience.org/library/papers/34320268PubMed
338358850Menin dependence: UBTF-ITD AML joins the club.Blood2024https://conductscience.org/library/papers/38358850PubMed
426740045Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes.Elife2016https://conductscience.org/library/papers/26740045PubMed
523361907Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.Blood2013https://conductscience.org/library/papers/23361907PubMed
626615201The long noncoding RNA Gm15055 represses Hoxa gene expression by recruiting PRC2 to the gene cluster.Nucleic Acids Res2016https://conductscience.org/library/papers/26615201PubMed
79058712Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis.Blood1997https://conductscience.org/library/papers/9058712PubMed
811840284Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia.Leukemia2002https://conductscience.org/library/papers/11840284PubMed
930205049Mutant NPM1 Maintains the Leukemic State through HOX Expression.Cancer Cell2018https://conductscience.org/library/papers/30205049PubMed
1031590682Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.Clin Epigenetics2019https://conductscience.org/library/papers/31590682PubMed
1129563185Structural and functional analysis of the DOT1L-AF10 complex reveals mechanistic insights into MLL-AF10-associated leukemogenesis.Genes Dev2018https://conductscience.org/library/papers/29563185PubMed
1237055414Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1.Blood Cancer J2023https://conductscience.org/library/papers/37055414PubMed
1331978781Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.Eur J Med Chem2020https://conductscience.org/library/papers/31978781PubMed
1432183947It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice.Cancer Cell2020https://conductscience.org/library/papers/32183947PubMed
1536264143A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL Inhibition.Cancer Discov2023https://conductscience.org/library/papers/36264143PubMed
1624472025High-affinity small-molecule inhibitors of the menin-mixed lineage leukemia (MLL) interaction closely mimic a natural protein-protein interaction.J Med Chem2014https://conductscience.org/library/papers/24472025PubMed
1732219447Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.Blood2020https://conductscience.org/library/papers/32219447PubMed
1828202494Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions.J Exp Med2017https://conductscience.org/library/papers/28202494PubMed
1912952893Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9.Genes Dev2003https://conductscience.org/library/papers/12952893PubMed
2017327400Evidence that the Pim1 kinase gene is a direct target of HOXA9.Blood2007https://conductscience.org/library/papers/17327400PubMed

See all 194 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42839017CTCF-associated chromatin changes between HOXD1 and HOXD8 contribute to TNBC progression.Exp Mol Med2026https://conductscience.org/library/papers/42839017PubMed
42564089Case Report: Acute monocytic leukemia mimicking large-vessel vasculitis on 18F-FDG PET/CT.Front Immunol2026https://conductscience.org/library/papers/42564089PubMed
42278415Menin Inhibition in Acute Myeloid Leukemia: Rewiring Leukemic Transcriptional Networks.Int J Mol Sci2026https://conductscience.org/library/papers/42278415PubMed
42122138Acute Myeloid Leukemias with Alterations of Lysine Methyltransferase 2A (KMT2A): Recent Therapeutic Developments.Cancers (Basel)2026https://conductscience.org/library/papers/42122138PubMed
42005175Sequential Transformation of Polycythemia Vera to Myelofibrosis and KMT2A-Rearranged Acute Myeloid Leukemia Treated With Revumenib: A Rare Case of Clonal Evolution.Cureus2026https://conductscience.org/library/papers/42005175PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HOXA@3197PubTator's text mininghttps://conductscience.org/library/genes/3197NCBI Gene
KMT2A4297PubTator's text mininghttps://conductscience.org/library/genes/4297NCBI Gene
MEN14221PubTator's text mininghttps://conductscience.org/library/genes/4221NCBI Gene
NPM14869PubTator's text mininghttps://conductscience.org/library/genes/4869NCBI Gene
NUP984928PubTator's text mininghttps://conductscience.org/library/genes/4928NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41350360

GET https://conductscience.org/api/papers/v1/41350360/references?page=2